Dr Lalchandani Labs Past Earnings Performance
Past criteria checks 1/6
Dr Lalchandani Labs's earnings have been declining at an average annual rate of -23.7%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 8.7% per year. Dr Lalchandani Labs's return on equity is 8.8%, and it has net margins of 20.4%.
Key information
-23.7%
Earnings growth rate
-23.5%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -8.7% |
| Return on equity | 8.8% |
| Net Margin | 20.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dr Lalchandani Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 42 | 9 | 6 | 0 |
| 30 Jun 24 | 45 | 7 | 6 | 0 |
| 31 Mar 24 | 48 | 6 | 6 | 0 |
| 31 Dec 23 | 51 | 0 | 7 | 0 |
| 30 Sep 23 | 55 | -7 | 8 | 0 |
| 30 Jun 23 | 53 | -11 | 8 | 0 |
| 31 Mar 23 | 50 | -16 | 8 | 0 |
| 31 Dec 22 | 53 | -13 | 12 | 0 |
| 30 Sep 22 | 55 | -11 | 15 | 0 |
| 30 Jun 22 | 84 | -1 | 15 | 0 |
| 31 Mar 22 | 113 | 9 | 15 | 0 |
| 31 Dec 21 | 132 | 14 | 12 | 0 |
| 30 Sep 21 | 151 | 19 | 32 | 0 |
| 30 Jun 21 | 124 | 14 | 32 | 0 |
| 31 Mar 21 | 98 | 10 | 8 | 0 |
| 31 Dec 20 | 78 | 8 | 18 | 0 |
| 30 Sep 20 | 58 | 3 | 28 | 0 |
| 30 Jun 20 | 59 | 4 | 28 | 0 |
| 31 Mar 20 | 61 | 5 | 28 | 0 |
| 31 Dec 19 | 59 | 5 | 26 | 0 |
| 30 Sep 19 | 57 | 7 | 25 | 0 |
| 30 Jun 19 | 55 | 6 | 25 | 0 |
| 31 Mar 19 | 53 | 5 | 25 | 0 |
| 31 Dec 18 | 40 | 1 | 17 | 0 |
| 30 Sep 18 | 28 | -3 | 10 | 0 |
| 30 Jun 18 | 28 | 0 | 10 | 0 |
| 31 Mar 18 | 28 | 3 | 10 | 0 |
| 31 Jan 18 | 41 | 4 | 3 | 0 |
| 02 Aug 17 | 64 | 25 | 4 | 0 |
| 31 Mar 17 | 45 | 7 | 2 | 0 |
| 31 Mar 16 | 30 | 3 | 1 | 0 |
| 31 Mar 15 | 19 | 3 | 1 | 0 |
| 31 Mar 14 | 14 | 0 | 0 | 0 |
Quality Earnings: 541299 has a large one-off gain of ₹13.8M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 541299 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 541299's earnings have declined by 23.7% per year over the past 5 years.
Accelerating Growth: 541299 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 541299 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (33.2%).
Return on Equity
High ROE: 541299's Return on Equity (8.8%) is considered low.